Jinze Shen

405 total citations
26 papers, 274 citations indexed

About

Jinze Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jinze Shen has authored 26 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Jinze Shen's work include Cancer-related molecular mechanisms research (19 papers), Circular RNAs in diseases (11 papers) and MicroRNA in disease regulation (10 papers). Jinze Shen is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), Circular RNAs in diseases (11 papers) and MicroRNA in disease regulation (10 papers). Jinze Shen collaborates with scholars based in China. Jinze Shen's co-authors include Shiwei Duan, Dayong Zhang, Yuchen Wu, Feng Zhu, Hanbing Li, Lihua Du, Yuchen Wu, Wenjing Ruan, Chen Sang and Feng Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Jinze Shen

24 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jinze Shen China	10	220	179	35	34	17	26	274
Roya Shahbazi Iran	7	243 1.1×	201 1.1×	40 1.1×	24 0.7×	14 0.8×	10	321
Suxia Luo China	11	225 1.0×	215 1.2×	34 1.0×	20 0.6×	15 0.9×	15	294
Xiaoyou Li China	8	287 1.3×	258 1.4×	46 1.3×	62 1.8×	17 1.0×	10	356
Pouria Jandaghi Canada	10	261 1.2×	128 0.7×	55 1.6×	27 0.8×	18 1.1×	14	327
Ahmet Arslan Türkiye	9	258 1.2×	199 1.1×	38 1.1×	16 0.5×	15 0.9×	14	322
Xiaolu Ge China	6	217 1.0×	194 1.1×	29 0.8×	25 0.7×	14 0.8×	9	270
Lin Shi China	9	226 1.0×	155 0.9×	72 2.1×	50 1.5×	9 0.5×	25	311
Xin Yuan China	10	234 1.1×	189 1.1×	21 0.6×	35 1.0×	21 1.2×	22	302
Noan‐Minh Chau Singapore	4	154 0.7×	159 0.9×	52 1.5×	26 0.8×	10 0.6×	7	226

Countries citing papers authored by Jinze Shen

Since Specialization

Citations

This map shows the geographic impact of Jinze Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinze Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinze Shen more than expected).

Fields of papers citing papers by Jinze Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinze Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinze Shen. The network helps show where Jinze Shen may publish in the future.

Co-authorship network of co-authors of Jinze Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Jinze Shen. A scholar is included among the top collaborators of Jinze Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinze Shen. Jinze Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Jinze, et al.. (2025). Recent Insights Into Wnt‐Related tRNA‐Derived Fragments (tRFs) in Human Diseases. Journal of Cellular Biochemistry. 126(1). e30702–e30702.

Shen, Jinze, et al.. (2024). RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy. Clinical and Translational Medicine. 14(9). e1788–e1788. 1 indexed citations

Shen, Jinze, et al.. (2024). RhoJ: an emerging biomarker and target in cancer research and treatment. Cancer Gene Therapy. 31(10). 1454–1464. 4 indexed citations

Shen, Jinze, et al.. (2024). Unveiling the role of tRNA-derived small RNAs in MAPK signaling pathway: implications for cancer and beyond. Frontiers in Genetics. 15. 1346852–1346852. 8 indexed citations

Xia, Qing, et al.. (2024). Cuproptosis-associated ncRNAs predict breast cancer subtypes. PLoS ONE. 19(2). e0299138–e0299138. 5 indexed citations

Shen, Jinze, et al.. (2024). NINJ1: Bridging lytic cell death and inflammation therapy. Cell Death and Disease. 15(11). 831–831. 7 indexed citations

Shen, Jinze, et al.. (2024). Exploring the multifaceted role of GCN1: Implications in cellular responses and disease pathogenesis. Biomedicine & Pharmacotherapy. 175. 116681–116681. 4 indexed citations

Tian, Mei, Yitong Guo, Qing Xia, et al.. (2024). MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential. Genes & Diseases. 12(4). 101287–101287. 3 indexed citations

Shen, Jinze, et al.. (2023). The tumor suppressor role and ceRNA network of miR-1294 in cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 31(1). 1–12. 6 indexed citations

10.

Shen, Jinze, et al.. (2023). Current insights into the oncogenic roles of lncRNA LINC00355. SHILAP Revista de lepidopterología. 2(6). 448–462. 2 indexed citations

11.

Xia, Qing, Zehua Wang, Jinze Shen, et al.. (2023). Disulfidptosis-associated lncRNAs predict breast cancer subtypes. Scientific Reports. 13(1). 16268–16268. 19 indexed citations

12.

Wang, Zehua, et al.. (2023). LINC00319: Unraveling the spectrum from gene regulation to clinical applications in cancer progression. Gene. 896. 148044–148044. 3 indexed citations

13.

Shen, Jinze, et al.. (2023). Current and future perspectives on the regulation and functions of miR-545 in cancer development. PubMed. 2(3). 142–154. 4 indexed citations

14.

Shen, Jinze, et al.. (2023). Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. SHILAP Revista de lepidopterología. 4(3). e288–e288. 31 indexed citations

15.

Shen, Jinze, et al.. (2022). LINC00963: A potential cancer diagnostic and therapeutic target. Biomedicine & Pharmacotherapy. 150. 113019–113019. 24 indexed citations

16.

Shen, Jinze, et al.. (2022). LINC00520: A Potential Diagnostic and Prognostic Biomarker in Cancer. Frontiers in Immunology. 13. 845418–845418. 13 indexed citations

17.

Shen, Jinze, Yuchen Wu, Wenjing Ruan, Feng Zhu, & Shiwei Duan. (2022). miR-1908 Dysregulation in Human Cancers. Frontiers in Oncology. 12. 857743–857743. 16 indexed citations

18.

Shen, Jinze, et al.. (2022). Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis. Biomarker Research. 10(1). 72–72. 45 indexed citations

19.

Zou, Mengsha, Jinze Shen, Yuchen Wu, et al.. (2022). Dysregulation of miR-411 in cancer: Causative factor for pathogenesis, diagnosis and prognosis. Biomedicine & Pharmacotherapy. 149. 112896–112896. 12 indexed citations

20.

Xia, Qing, et al.. (2022). LINC00324 in cancer: Regulatory and therapeutic implications. Frontiers in Oncology. 12. 1039366–1039366. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact